Search research articles
Contact Us
Filters
Showing results (151-160 of 244) with videos related to
Page
of 25
Sort By:
Leukemia & Lymphoma
|
May 7, 2024
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study
Farhad Ravandi, Marion Subklewe, Roland B Walter, et al.
Blood Advances
|
February 24, 2026
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion
Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
Deutsches Arzteblatt International
|
March 12, 2024
Friday Leukemia-a Structural Phenomenon
Christian Rausch, Chiara Arnreich, Maja Rothenberg-Thurley, et al.
Journal for Immunotherapy of Cancer
|
May 17, 2022
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL
Kai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Haematologica
|
June 16, 2018
Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older
Victoria V Prassek, Maja Rothenberg-Thurley, Maria C Sauerland, et al.
Cancer Immunology Research
|
April 11, 2023
Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy
Kai Rejeski, David M Cordas Dos Santos, Nathan H Parker, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
November 13, 2023
Substantial differences in perception of disease severity between post COVID-19 patients, internists, and psychiatrists or psychologists: the Health Perception Gap and its clinical implications
Michael Ruzicka, Gerardo Jesus Ibarra Fonseca, Simone Sachenbacher, et al.
The New England Journal of Medicine
|
March 4, 2026
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome
Adrian Gottschlich, Veit Bücklein, Karim El-Marouk, et al.
Cancer Immunology, Immunotherapy : CII
|
May 22, 2025
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy
Anna Reischer, Alexandra Leutbecher, Björn Hiller, et al.
Leukemia
|
January 8, 2021
A modular and controllable T cell therapy platform for acute myeloid leukemia
Mohamed-Reda Benmebarek, Bruno L Cadilha, Monika Herrmann, et al.
Page
of 25
Search research articles
Search
Showing results (151-160 of 244) with videos related to
Sort By:
Page
of 25
Leukemia & Lymphoma
|
May 7, 2024
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study
Farhad Ravandi, Marion Subklewe, Roland B Walter, et al.
Blood Advances
|
February 24, 2026
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion
Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
Deutsches Arzteblatt International
|
March 12, 2024
Friday Leukemia-a Structural Phenomenon
Christian Rausch, Chiara Arnreich, Maja Rothenberg-Thurley, et al.
Journal for Immunotherapy of Cancer
|
May 17, 2022
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL
Kai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Haematologica
|
June 16, 2018
Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older
Victoria V Prassek, Maja Rothenberg-Thurley, Maria C Sauerland, et al.
Cancer Immunology Research
|
April 11, 2023
Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy
Kai Rejeski, David M Cordas Dos Santos, Nathan H Parker, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
November 13, 2023
Substantial differences in perception of disease severity between post COVID-19 patients, internists, and psychiatrists or psychologists: the Health Perception Gap and its clinical implications
Michael Ruzicka, Gerardo Jesus Ibarra Fonseca, Simone Sachenbacher, et al.
The New England Journal of Medicine
|
March 4, 2026
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome
Adrian Gottschlich, Veit Bücklein, Karim El-Marouk, et al.
Cancer Immunology, Immunotherapy : CII
|
May 22, 2025
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy
Anna Reischer, Alexandra Leutbecher, Björn Hiller, et al.
Leukemia
|
January 8, 2021
A modular and controllable T cell therapy platform for acute myeloid leukemia
Mohamed-Reda Benmebarek, Bruno L Cadilha, Monika Herrmann, et al.
Page
of 25